[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Coronary Drug-Eluting Stent Market Report 2017

September 2017 | 122 pages | ID: A04145037D3EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Coronary Drug-Eluting Stent market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Coronary Drug-Eluting Stent for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Coronary Drug-Eluting Stent market competition by top manufacturers/players, with Coronary Drug-Eluting Stent sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Boston Scientific
  • Cordis
  • Abbott
  • Advantec Vascular
  • B.Braun Melsengen AG
  • Biosensors
  • Biotronik
  • Blue Medical
  • DISA Vascular
  • Essen
  • Medtronic Vascular
  • MicroPort Medical
  • MIV Therapeutics
  • Orbusneich
  • Promed Medical
  • Relisys Medical
  • Reva Medical
  • Sahajanand
  • Sino Medical
  • Sorin
  • Terumo Medical
  • Translumina
  • Vascular Concepts
  • JW Medical Systems
  • Kinhely
  • Lepu Medical
  • Medfavour Medical
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Durable Polymer Drug-eluting Stents
  • Bioabsorbable Polymer Drug-eluting Stent
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Coronary Drug-Eluting Stent for each application, includin
  • Coronary Heart Disease
  • Clinical
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Coronary Drug-Eluting Stent Market Report 2017

1 CORONARY DRUG-ELUTING STENT OVERVIEW

1.1 Product Overview and Scope of Coronary Drug-Eluting Stent
1.2 Classification of Coronary Drug-Eluting Stent by Product Category
  1.2.1 Asia-Pacific Coronary Drug-Eluting Stent Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Coronary Drug-Eluting Stent Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Durable Polymer Drug-eluting Stents
  1.2.4 Bioabsorbable Polymer Drug-eluting Stent
1.3 Asia-Pacific Coronary Drug-Eluting Stent Market by Application/End Users
  1.3.1 Asia-Pacific Coronary Drug-Eluting Stent Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Coronary Heart Disease
  1.3.3 Clinical
1.4 Asia-Pacific Coronary Drug-Eluting Stent Market by Region
  1.4.1 Asia-Pacific Coronary Drug-Eluting Stent Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Coronary Drug-Eluting Stent (2012-2022)
  1.5.1 Asia-Pacific Coronary Drug-Eluting Stent Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC CORONARY DRUG-ELUTING STENT COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Coronary Drug-Eluting Stent Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Coronary Drug-Eluting Stent Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Coronary Drug-Eluting Stent (Volume and Value) by Type
  2.2.1 Asia-Pacific Coronary Drug-Eluting Stent Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Coronary Drug-Eluting Stent (Volume) by Application
2.4 Asia-Pacific Coronary Drug-Eluting Stent (Volume and Value) by Region
  2.4.1 Asia-Pacific Coronary Drug-Eluting Stent Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue and Market Share by Region (2012-2017)

3 CHINA CORONARY DRUG-ELUTING STENT (VOLUME, VALUE AND SALES PRICE)

3.1 China Coronary Drug-Eluting Stent Sales and Value (2012-2017)
  3.1.1 China Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
  3.1.3 China Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
3.2 China Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
3.3 China Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

4 JAPAN CORONARY DRUG-ELUTING STENT (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Coronary Drug-Eluting Stent Sales and Value (2012-2017)
  4.1.1 Japan Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
4.2 Japan Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
4.3 Japan Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

5 SOUTH KOREA CORONARY DRUG-ELUTING STENT (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Coronary Drug-Eluting Stent Sales and Value (2012-2017)
  5.1.1 South Korea Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
5.2 South Korea Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
5.3 South Korea Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

6 TAIWAN CORONARY DRUG-ELUTING STENT (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Coronary Drug-Eluting Stent Sales and Value (2012-2017)
  6.1.1 Taiwan Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
6.2 Taiwan Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
6.3 Taiwan Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

7 INDIA CORONARY DRUG-ELUTING STENT (VOLUME, VALUE AND SALES PRICE)

7.1 India Coronary Drug-Eluting Stent Sales and Value (2012-2017)
  7.1.1 India Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
  7.1.3 India Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
7.2 India Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
7.3 India Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

8 SOUTHEAST ASIA CORONARY DRUG-ELUTING STENT (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Coronary Drug-Eluting Stent Sales and Value (2012-2017)
  8.1.1 Southeast Asia Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
8.2 Southeast Asia Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
8.3 Southeast Asia Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

9 AUSTRALIA CORONARY DRUG-ELUTING STENT (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Coronary Drug-Eluting Stent Sales and Value (2012-2017)
  9.1.1 Australia Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
9.2 Australia Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
9.3 Australia Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

10 ASIA-PACIFIC CORONARY DRUG-ELUTING STENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Boston Scientific
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Boston Scientific Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Cordis
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Cordis Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Abbott
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Abbott Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Advantec Vascular
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Advantec Vascular Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 B.Braun Melsengen AG
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 B.Braun Melsengen AG Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Biosensors
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Biosensors Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Biotronik
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Biotronik Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Blue Medical
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Blue Medical Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 DISA Vascular
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 DISA Vascular Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Essen
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Essen Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Medtronic Vascular
10.12 MicroPort Medical
10.13 MIV Therapeutics
10.14 Orbusneich
10.15 Promed Medical
10.16 Relisys Medical
10.17 Reva Medical
10.18 Sahajanand
10.19 Sino Medical
10.20 Sorin
10.21 Terumo Medical
10.22 Translumina
10.23 Vascular Concepts
10.24 JW Medical Systems
10.25 Kinhely
10.26 Lepu Medical
10.27 Medfavour Medical

11 CORONARY DRUG-ELUTING STENT MANUFACTURING COST ANALYSIS

11.1 Coronary Drug-Eluting Stent Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Coronary Drug-Eluting Stent

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Coronary Drug-Eluting Stent Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Coronary Drug-Eluting Stent Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC CORONARY DRUG-ELUTING STENT MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Coronary Drug-Eluting Stent Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Coronary Drug-Eluting Stent Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Coronary Drug-Eluting Stent Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Coronary Drug-Eluting Stent Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Coronary Drug-Eluting Stent Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Coronary Drug-Eluting Stent Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Coronary Drug-Eluting Stent Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Coronary Drug-Eluting Stent Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Coronary Drug-Eluting Stent Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Coronary Drug-Eluting Stent
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales Volume Market Share by Type (Product Category) in 2016
Figure Durable Polymer Drug-eluting Stents Product Picture
Figure Bioabsorbable Polymer Drug-eluting Stent Product Picture
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Coronary Drug-Eluting Stent by Application in 2016
Figure Coronary Heart Disease Examples
Table Key Downstream Customer in Coronary Heart Disease
Figure Clinical Examples
Table Key Downstream Customer in Clinical
Figure Asia-Pacific Coronary Drug-Eluting Stent Market Size (Million USD) by Region (2012-2022)
Figure China Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Coronary Drug-Eluting Stent Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Coronary Drug-Eluting Stent Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Coronary Drug-Eluting Stent Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Coronary Drug-Eluting Stent Sales Share by Players/Suppliers
Figure Asia-Pacific Coronary Drug-Eluting Stent Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Coronary Drug-Eluting Stent Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Coronary Drug-Eluting Stent Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Coronary Drug-Eluting Stent Revenue Share by Players
Figure 2017 Asia-Pacific Coronary Drug-Eluting Stent Revenue Share by Players
Table Asia-Pacific Coronary Drug-Eluting Stent Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Coronary Drug-Eluting Stent Sales Share by Type (2012-2017)
Figure Sales Market Share of Coronary Drug-Eluting Stent by Type (2012-2017)
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Coronary Drug-Eluting Stent Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Coronary Drug-Eluting Stent Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Coronary Drug-Eluting Stent by Type (2012-2017)
Figure Asia-Pacific Coronary Drug-Eluting Stent Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Coronary Drug-Eluting Stent Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Coronary Drug-Eluting Stent Sales Share by Region (2012-2017)
Figure Sales Market Share of Coronary Drug-Eluting Stent by Region (2012-2017)
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales Market Share by Region in 2016
Table Asia-Pacific Coronary Drug-Eluting Stent Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Coronary Drug-Eluting Stent Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Coronary Drug-Eluting Stent by Region (2012-2017)
Figure Asia-Pacific Coronary Drug-Eluting Stent Revenue Market Share by Region in 2016
Table Asia-Pacific Coronary Drug-Eluting Stent Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Coronary Drug-Eluting Stent Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales Market Share by Application (2012-2017)
Figure China Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure China Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Coronary Drug-Eluting Stent Sales Price (USD/Unit) Trend (2012-2017)
Table China Coronary Drug-Eluting Stent Sales Volume (K Units) by Type (2012-2017)
Table China Coronary Drug-Eluting Stent Sales Volume Market Share by Type (2012-2017)
Figure China Coronary Drug-Eluting Stent Sales Volume Market Share by Type in 2016
Table China Coronary Drug-Eluting Stent Sales Volume (K Units) by Applications (2012-2017)
Table China Coronary Drug-Eluting Stent Sales Volume Market Share by Application (2012-2017)
Figure China Coronary Drug-Eluting Stent Sales Volume Market Share by Application in 2016
Figure Japan Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Coronary Drug-Eluting Stent Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Coronary Drug-Eluting Stent Sales Volume (K Units) by Type (2012-2017)
Table Japan Coronary Drug-Eluting Stent Sales Volume Market Share by Type (2012-2017)
Figure Japan Coronary Drug-Eluting Stent Sales Volume Market Share by Type in 2016
Table Japan Coronary Drug-Eluting Stent Sales Volume (K Units) by Applications (2012-2017)
Table Japan Coronary Drug-Eluting Stent Sales Volume Market Share by Application (2012-2017)
Figure Japan Coronary Drug-Eluting Stent Sales Volume Market Share by Application in 2016
Figure South Korea Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Coronary Drug-Eluting Stent Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Coronary Drug-Eluting Stent Sales Volume (K Units) by Type (2012-2017)
Table South Korea Coronary Drug-Eluting Stent Sales Volume Market Share by Type (2012-2017)
Figure South Korea Coronary Drug-Eluting Stent Sales Volume Market Share by Type in 2016
Table South Korea Coronary Drug-Eluting Stent Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Coronary Drug-Eluting Stent Sales Volume Market Share by Application (2012-2017)
Figure South Korea Coronary Drug-Eluting Stent Sales Volume Market Share by Application in 2016
Figure Taiwan Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Coronary Drug-Eluting Stent Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Coronary Drug-Eluting Stent Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Coronary Drug-Eluting Stent Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Coronary Drug-Eluting Stent Sales Volume Market Share by Type in 2016
Table Taiwan Coronary Drug-Eluting Stent Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Coronary Drug-Eluting Stent Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Coronary Drug-Eluting Stent Sales Volume Market Share by Application in 2016
Figure India Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure India Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Coronary Drug-Eluting Stent Sales Price (USD/Unit) Trend (2012-2017)
Table India Coronary Drug-Eluting Stent Sales Volume (K Units) by Type (2012-2017)
Table India Coronary Drug-Eluting Stent Sales Volume Market Share by Type (2012-2017)
Figure India Coronary Drug-Eluting Stent Sales Volume Market Share by Type in 2016
Table India Coronary Drug-Eluting Stent Sales Volume (K Units) by Application (2012-2017)
Table India Coronary Drug-Eluting Stent Sales Volume Market Share by Application (2012-2017)
Figure India Coronary Drug-Eluting Stent Sales Volume Market Share by Application in 2016
Figure Southeast Asia Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Coronary Drug-Eluting Stent Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Coronary Drug-Eluting Stent Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Coronary Drug-Eluting Stent Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Coronary Drug-Eluting Stent Sales Volume Market Share by Type in 2016
Table Southeast Asia Coronary Drug-Eluting Stent Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Coronary Drug-Eluting Stent Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Coronary Drug-Eluting Stent Sales Volume Market Share by Application in 2016
Figure Australia Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Coronary Drug-Eluting Stent Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Coronary Drug-Eluting Stent Sales Volume (K Units) by Type (2012-2017)
Table Australia Coronary Drug-Eluting Stent Sales Volume Market Share by Type (2012-2017)
Figure Australia Coronary Drug-Eluting Stent Sales Volume Market Share by Type in 2016
Table Australia Coronary Drug-Eluting Stent Sales Volume (K Units) by Applications (2012-2017)
Table Australia Coronary Drug-Eluting Stent Sales Volume Market Share by Application (2012-2017)
Figure Australia Coronary Drug-Eluting Stent Sales Volume Market Share by Application in 2016
Table Boston Scientific Coronary Drug-Eluting Stent Basic Information List
Table Boston Scientific Coronary Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boston Scientific Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure Boston Scientific Coronary Drug-Eluting Stent Sales Market Share in Asia-Pacific (2012-2017)
Figure Boston Scientific Coronary Drug-Eluting Stent Revenue Market Share in Asia-Pacific (2012-2017)
Table Cordis Coronary Drug-Eluting Stent Basic Information List
Table Cordis Coronary Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cordis Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure Cordis Coronary Drug-Eluting Stent Sales Market Share in Asia-Pacific (2012-2017)
Figure Cordis Coronary Drug-Eluting Stent Revenue Market Share in Asia-Pacific (2012-2017)
Table Abbott Coronary Drug-Eluting Stent Basic Information List
Table Abbott Coronary Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Coronary Drug-Eluting Stent Sales Market Share in Asia-Pacific (2012-2017)
Figure Abbott Coronary Drug-Eluting Stent Revenue Market Share in Asia-Pacific (2012-2017)
Table Advantec Vascular Coronary Drug-Eluting Stent Basic Information List
Table Advantec Vascular Coronary Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Advantec Vascular Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure Advantec Vascular Coronary Drug-Eluting Stent Sales Market Share in Asia-Pacific (2012-2017)
Figure Advantec Vascular Coronary Drug-Eluting Stent Revenue Market Share in Asia-Pacific (2012-2017)
Table B.Braun Melsengen AG Coronary Drug-Eluting Stent Basic Information List
Table B.Braun Melsengen AG Coronary Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure B.Braun Melsengen AG Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure B.Braun Melsengen AG Coronary Drug-Eluting Stent Sales Market Share in Asia-Pacific (2012-2017)
Figure B.Braun Melsengen AG Coronary Drug-Eluting Stent Revenue Market Share in Asia-Pacific (2012-2017)
Table Biosensors Coronary Drug-Eluting Stent Basic Information List
Table Biosensors Coronary Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biosensors Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure Biosensors Coronary Drug-Eluting Stent Sales Market Share in Asia-Pacific (2012-2017)
Figure Biosensors Coronary Drug-Eluting Stent Revenue Market Share in Asia-Pacific (2012-2017)
Table Biotronik Coronary Drug-Eluting Stent Basic Information List
Table Biotronik Coronary Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biotronik Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure Biotronik Coronary Drug-Eluting Stent Sales Market Share in Asia-Pacific (2012-2017)
Figure Biotronik Coronary Drug-Eluting Stent Revenue Market Share in Asia-Pacific (2012-2017)
Table Blue Medical Coronary Drug-Eluting Stent Basic Information List
Table Blue Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Blue Medical Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure Blue Medical Coronary Drug-Eluting Stent Sales Market Share in Asia-Pacific (2012-2017)
Figure Blue Medical Coronary Drug-Eluting Stent Revenue Market Share in Asia-Pacific (2012-2017)
Table DISA Vascular Coronary Drug-Eluting Stent Basic Information List
Table DISA Vascular Coronary Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DISA Vascular Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure DISA Vascular Coronary Drug-Eluting Stent Sales Market Share in Asia-Pacific (2012-2017)
Figure DISA Vascular Coronary Drug-Eluting Stent Revenue Market Share in Asia-Pacific (2012-2017)
Table Essen Coronary Drug-Eluting Stent Basic Information List
Table Essen Coronary Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Essen Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate (2012-2017)
Figure Essen Coronary Drug-Eluting Stent Sales Market Share in Asia-Pacific (2012-2017)
Figure Essen Coronary Drug-Eluting Stent Revenue Market Share in Asia-Pacific (2012-2017)
Table Medtronic Vascular Coronary Drug-Eluting Stent Basic Information List
Table MicroPort Medical Coronary Drug-Eluting Stent Basic Information List
Table MIV Therapeutics Coronary Drug-Eluting Stent Basic Information List
Table Orbusneich Coronary Drug-Eluting Stent Basic Information List
Table Promed Medical Coronary Drug-Eluting Stent Basic Information List
Table Relisys Medical Coronary Drug-Eluting Stent Basic Information List
Table Reva Medical Coronary Drug-Eluting Stent Basic Information List
Table Sahajanand Coronary Drug-Eluting Stent Basic Information List
Table Sino Medical Coronary Drug-Eluting Stent Basic Information List
Table Sorin Coronary Drug-Eluting Stent Basic Information List
Table Terumo Medical Coronary Drug-Eluting Stent Basic Information List
Table Translumina Coronary Drug-Eluting Stent Basic Information List
Table Vascular Concepts Coronary Drug-Eluting Stent Basic Information List
Table JW Medical Systems Coronary Drug-Eluting Stent Basic Information List
Table Kinhely Coronary Drug-Eluting Stent Basic Information List
Table Lepu Medical Coronary Drug-Eluting Stent Basic Information List
Table Medfavour Medical Coronary Drug-Eluting Stent Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Coronary Drug-Eluting Stent
Figure Manufacturing Process Analysis of Coronary Drug-Eluting Stent
Figure Coronary Drug-Eluting Stent Industrial Chain Analysis
Table Raw Materials Sources of Coronary Drug-Eluting Stent Major Manufacturers in 2016
Table Major Buyers of Coronary Drug-Eluting Stent
Table Distributors/Traders List
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Coronary Drug-Eluting Stent Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Coronary Drug-Eluting Stent Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Revenue Market Share Forecast by Region in 2022
Figure China Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Coronary Drug-Eluting Stent Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Coronary Drug-Eluting Stent Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Coronary Drug-Eluting Stent Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Coronary Drug-Eluting Stent Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Coronary Drug-Eluting Stent Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Coronary Drug-Eluting Stent Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Coronary Drug-Eluting Stent Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories